US Stock MarketDetailed Quotes

CLYM Climb Bio

Watchlist
  • 1.820
  • -0.050-2.67%
Close Jan 23 16:00 ET
  • 1.800
  • -0.020-1.10%
Post 16:30 ET
122.49MMarket Cap-1.07P/E (TTM)

Climb Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Climb Bio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Climb Bio Earnings Reports

  • Climb Bio | 8-K: Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

    Nov 12, 2024 16:42 ET

  • Climb Bio | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 16:03 ET

  • Eliem Therapeutics | 8-K: Eliem Therapeutics Reports Second Quarter Financial Results

    Aug 14, 2024 06:16 ET

  • Eliem Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 06:11 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +4.10%
    Cars.com
    CARS
    +3.38%
    Lantheus
    LNTH
    +2.35%
    New Fortress Energy
    NFE
    +2.12%
    eBay
    EBAY
    +1.36%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 23, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data